Literature DB >> 16291239

Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.

Manuchair Ebadi1, Sushil K Sharma, Pedram Ghafourifar, Holly Brown-Borg, H El Refaey.   

Abstract

Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta and in other subcortical nuclei associated with a widespread occurrence of Lewy bodies. The causes of cell death in Parkinson's disease are still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative stress has been proposed. We have examined 3-morpholinosydnonimine (SIN-1)-induced apoptosis in control and metallothionein-overexpressing dopaminergic neurons, with a primary objective to determine the neuroprotective potential of metallothionein (MT) against peroxynitrite-induced neurodegeneration in PD. SIN-1 induced lipid peroxidation and triggered plasma membrane blebbing. In addition, it caused DNA fragmentation, alpha-synuclein induction, and intramitochondrial accumulation of metal ions (copper, iron, zinc, and calcium), and it enhanced the synthesis of 8-hydroxy-2-deoxyguanosine. Furthermore, it downregulated the expression of Bcl-2 and poly(adenosine diphosphate-ribose) polymerase, but upregulated the expression of caspase-3 and Bax in dopaminergic (SK-N-SH) neurons. SIN-1 induced apoptosis in aging mitochondrial genome knockout cells, alpha-synuclein-transfected cells, metallothionein double-knockout cells, and caspase-3-overexpressed dopaminergic neurons. SIN-1-induced changes were attenuated with selegiline or in metallothionein-transgenic striatal fetal stem cells. SIN-1-induced oxidation of dopamine (DA) to dihydroxyphenylacetaldehyde (DopaL) was attenuated in metallothionein-transgenic fetal stem cells and in cells transfected with a mitochondrial genome, and was enhanced in aging mitochondrial genome knockout cells, in metallothionein double-knockout cells, and caspase-3 gene-overexpressing dopaminergic neurons. Selegiline, melatonin, ubiquinone, and metallothionein suppressed SIN-1-induced downregulation of a mitochondrial genome and upregulation of caspase-3 as determined by reverse transcription polymerase chain reaction. These studies provide evidence that nitric oxide synthase activation and peroxynitrite ion overproduction may be involved in the etiopathogenesis of PD, and that metallothionein gene induction may provide neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291239     DOI: 10.1016/S0076-6879(05)96024-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  21 in total

1.  Up-regulation of metallothionein gene expression in parkinsonian astrocytes.

Authors:  Gregory J Michael; Sharmin Esmailzadeh; Linda B Moran; Lynne Christian; Ronald K B Pearce; Manuel B Graeber
Journal:  Neurogenetics       Date:  2011-07-29       Impact factor: 2.660

Review 2.  Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Authors:  Manuchair Ebadi; Holly Brown-Borg; Hesham El Refaey; Brij B Singh; Scott Garrett; Shaik Shavali; Sushil K Sharma
Journal:  Brain Res Mol Brain Res       Date:  2005-03-24

3.  Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.

Authors:  Patcharee Kooncumchoo; Sushil Sharma; James Porter; Piyarat Govitrapong; Manuchir Ebadi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.

Authors:  Hui Ying Tan; Khuen Yen Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Cell Mol Neurobiol       Date:  2019-08-21       Impact factor: 5.046

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  The antiapoptotic activity of melatonin in neurodegenerative diseases.

Authors:  Xin Wang
Journal:  CNS Neurosci Ther       Date:  2009-10-10       Impact factor: 5.243

7.  Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity.

Authors:  Zhenquan Jia; Seema Hallur; Hong Zhu; Yunbo Li; Hara P Misra
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

Review 8.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 9.  Clinical significance of metallothioneins in cell therapy and nanomedicine.

Authors:  Sushil Sharma; Afsha Rais; Ranbir Sandhu; Wynand Nel; Manuchair Ebadi
Journal:  Int J Nanomedicine       Date:  2013-04-16

10.  The Balance between Life and Death of Cells: Roles of Metallothioneins.

Authors:  Allan Evald Nielsen; Adam Bohr; Milena Penkowa
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.